Aliases & Classifications for Erythroplakia

MalaCards integrated aliases for Erythroplakia:

Name: Erythroplakia 53
Erythroplasia 72

Classifications:



External Ids:

UMLS 72 C0014818

Summaries for Erythroplakia

MalaCards based summary : Erythroplakia, also known as erythroplasia, is related to leukoplakia and in situ carcinoma. An important gene associated with Erythroplakia is ABCG2 (ATP Binding Cassette Subfamily G Member 2 (Junior Blood Group)), and among its related pathways/superpathways are Glucose / Energy Metabolism and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Metformin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and tongue.

Wikipedia : 75 Erythroplakia is a clinical term to describe any erythematous (red) area on a mucous membrane, that... more...

Related Diseases for Erythroplakia

Graphical network of the top 20 diseases related to Erythroplakia:



Diseases related to Erythroplakia

Symptoms & Phenotypes for Erythroplakia

Drugs & Therapeutics for Erythroplakia

Drugs for Erythroplakia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 17, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metformin Approved Phase 4 657-24-9 4091 14219
2 Hypoglycemic Agents Phase 4
3
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
4 Hemostatics Phase 3
5 Coagulants Phase 3
6 Tolonium Chloride Phase 3
7 calcium heparin Phase 3
8
Aminolevulinic acid Approved Phase 2 106-60-5 137
9 Dermatologic Agents Phase 2
10 Photosensitizing Agents Phase 2
11
Erythromycin Approved, Investigational, Vet_approved Phase 1 114-07-8 441411 12560
12
Isotretinoin Approved Phase 1 4759-48-2 5282379 5538
13 Erythromycin stearate Phase 1
14 Erythromycin Ethylsuccinate Phase 1
15 Erythromycin Estolate Phase 1
16
Ethanol Approved 64-17-5 702
17 Pharmaceutical Solutions

Interventional clinical trials:

(showing 15, show less)
# Name Status NCT ID Phase Drugs
1 Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions: A Randomised Clinical Trial Recruiting NCT03684707 Phase 4 Metformin Hcl 500Mg 24Hr Sa Tab
2 Comparing the Test Characteristics of Three Oral Cancer Screening Techniques:1)Unaided Visual Examination 2)VelScope Examination and 3)Toluidine Blue Application, by Trained Primary Health Care Workers in Mumbai, India. Unknown status NCT00655421 Phase 3
3 Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions: A Randomized Clinical Trial (Part 1) Recruiting NCT03685409 Phase 3 Metformin Hydrochloride 500 MG;Placebo Oral Tablet
4 A Combined Phase I/II Single Site Study to Determine the Safety and Efficacy of Photodynamic Therapy (PDT) Utilizing 5-aminolevulinic Acid (5-ALA) and PDT in the Treatment of Premalignant Oral and/or Oropharynx Lesions. Completed NCT00571974 Phase 1, Phase 2 5-Aminolevulinic Acid (Levulan KerastickTM)
5 M4OC-Prevent: Metformin for Oral Cancer Prevention Active, not recruiting NCT02581137 Phase 2 Metformin Hydrochloride
6 Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - A Phase 2 Randomized Double-blind Placebo Controlled Clinical Trial Not yet recruiting NCT03990636 Phase 2 Metil 5-aminolevulinate
7 A Phase 1, Randomized, Double-blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of SBS-101 After Intraoral Application in Patients With Oral Premalignant Lesions (OPL) Not yet recruiting NCT03939364 Phase 1 SBS-101;Placebo
8 Diagnostic Accuracy Of Colposcopic Examination in Patients With Oral Dysplastic Lesion (Diagnostic Accuracy Study) Unknown status NCT03075098
9 Interventional Study to Determine the Effectiveness of Medium Intensity Verses Low Intensity Tobacco Use Prevention and Cessation Intervention in the Unorganized Sector of Zari Workers in Mumbai Unknown status NCT02103868
10 Natural History of Oral Cancer Precursors Completed NCT00179361
11 Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions Completed NCT02217358
12 Fluorescence &Amp; Reflectance Imaging to Detect Oral Neoplasia Recruiting NCT00542373
13 The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw Recruiting NCT03418454
14 Localized.Diffuse Vocal Folds Irregularites:Combined Use of Laryngostroboscopy and Histopathology in Diffrential Diagnosis Not yet recruiting NCT04006197
15 Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions Not yet recruiting NCT03682562

Search NIH Clinical Center for Erythroplakia

Genetic Tests for Erythroplakia

Anatomical Context for Erythroplakia

MalaCards organs/tissues related to Erythroplakia:

41
Skin, Testes, Tongue, Liver, Cervix, Salivary Gland, Lymph Node

Publications for Erythroplakia

Articles related to Erythroplakia:

(showing 449, show less)
# Title Authors PMID Year
1
Oral Epithelial Dysplasia and Premalignancy. 38
30887394 2019
2
Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat. 38
30585302 2019
3
Podoplanin and ABCG2 expression in oral erythroplakia revisited: Potential evidence for cancer stem cells driving the process of field cancerization. 38
31300272 2019
4
Bibliometric analysis of the top-cited articles on oral erythroplakia and leukoplakia. 38
31006140 2019
5
Smokeless tobacco use and oral neoplasia among urban Indian women. 38
31348589 2019
6
Assessing Oral Cancer Awareness Among Dental Students. 38
29446005 2019
7
White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis. 38
31090142 2019
8
Retrospective analysis of oral erythroplakia focused on multiple and multifocal malignant behavior. 38
31188512 2019
9
Accuracy of dermoscopy in distinguishing erythroplasia of Queyrat from common forms of chronic balanitis: results from a multicentric observational study. 38
30468529 2019
10
Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines. 38
30997072 2019
11
Impact of oral potentially malignant disorder subtypes on all-cause and cause-specific mortality in males. 38
30592115 2019
12
Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review. 38
30921006 2019
13
Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities. 38
30693460 2019
14
Micronuclei in Exfoliated Oral Epithelial Cells in Tobacco Users and Controls with Various Oral Lesions: A Study from Gujarat, India. 38
30906725 2019
15
Penile intraepithelial neoplasia: Nomenclature, incidence and progression to malignancy in the Netherlands. 38
30508877 2019
16
Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case report. 38
30537068 2019
17
Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature. 38
30892161 2019
18
Is Periodontitis Independently Associated with Potentially Malignant Disorders of the Oral Cavity? 38
30678451 2019
19
Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program. 38
30527244 2018
20
Tooth and Advanced Oral Submucous Fibrosis Obscuring Buccal Squamous Cell Carcinoma: A Case Report and Literature Review. 38
30868016 2018
21
Prevalence of oral mucosal lesions among smokeless tobacco usage: A cross-sectional study. 38
30829279 2018
22
Assessing Oral Cancer Awareness Among Dentists. 38
28251522 2018
23
Concentric Ring Probe for Bioimpedance Spectroscopic Measurements: Design and Ex Vivo Feasibility Testing on Pork Oral Tissues. 38
30308986 2018
24
Prospective Evaluation of Surgical Outcome After Transoral CO2 Laser Resection of Potentially Malignant and Early Oral Malignancy. 38
30288008 2018
25
[Penile intra-epithelial neoplasia]. 38
29937064 2018
26
Frequency of Pathologic Changes in the Oral Cavity in Patients Subjected to Long-term Pharmacologic Immunosuppressive Therapy After Kidney, Liver, and Hematopoietic Cell Transplantation. 38
30177132 2018
27
Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. 38
29738071 2018
28
Oral health consequences of smokeless tobacco use. 38
30264752 2018
29
Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy. 38
29888705 2018
30
Management update of potentially premalignant oral epithelial lesions. 38
29656948 2018
31
Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. 38
29606637 2018
32
Clinical features and presentation of oral potentially malignant disorders. 38
29673799 2018
33
Oral potentially malignant disorders: risk of progression to malignancy. 38
29396319 2018
34
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight. 38
29751770 2018
35
Bibliometric analysis of a century of research on oral erythroplakia and leukoplakia. 38
29344996 2018
36
Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation? 38
29480603 2018
37
Nonvenereal Penile Dermatoses: A Retrospective Study. 38
29644193 2018
38
"Omics" in oral cancer: New approaches for biomarker discovery. 38
29247855 2018
39
Oral erythroplakia-What is it? 38
29480616 2018
40
Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review. 38
28480637 2018
41
Intraoral Potentially Malignant Disorders in a Brazilian Oral Pathology Service: Epidemiological, Clinical, and Histopathological Findings. 38
29686705 2018
42
The ultrastructural features of the premalignant oral lesions. 38
29940634 2018
43
The 150 most important questions in cancer research and clinical oncology series: questions 86-93 : Edited by Chinese Journal of Cancer. 38
29357949 2018
44
Raman exfoliative cytology for oral precancer diagnosis. 38
29139244 2017
45
Human papillomavirus infection in oral potentially malignant disorders and cancer. 38
28886585 2017
46
Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature. 38
29183344 2017
47
Human Papillomavirus as a Potential Risk Factor for Oral Premalignant Lesions. 38
29479901 2017
48
Urologic Dermatology: a Review. 38
28667573 2017
49
Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck. 38
28858212 2017
50
Malignant Transformation in Leukoplakia and Its Associated Factors in Southern Iran: A Hospital Based Experience. 38
28894713 2017
51
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision. 38
28209454 2017
52
A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients. 38
28545482 2017
53
Topical agents for oral cancer chemoprevention: A systematic review of the literature. 38
28351570 2017
54
Knowledge, Attitude, and Practice of Women in Slums of Pimpri, Chinchwad, Pune, Maharashtra, India, regarding Usage of Mishri. 38
28258268 2017
55
[Precancerous lesions of the buccal epithelium]. 38
27939087 2017
56
Pan masala habits and risk of oral precancer: A cross-sectional survey in 0.45 million people of North India. 38
28316915 2017
57
[Oral cancer -diagnosis and therapy-.] 38
28947694 2017
58
Erythroplasia of Queyrat treated by laser and light modalities: a systematic review. 38
27324019 2016
59
Dermoscopy in General Dermatology: A Practical Overview. 38
27613297 2016
60
The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review. 38
28007674 2016
61
Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy (MAL-PDT): case report and review of the literature. 38
27905695 2016
62
[Dermatological diseases of the male genital tract]. 38
27590352 2016
63
Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date. 38
27688118 2016
64
Prevalence and factors associated with oral potentially malignant disorders in Brazil's rural workers. 38
27090966 2016
65
Erythroplasia of Queyrat treated with topical 5-fluorouracil. 38
28300890 2016
66
Prevalence and distribution of oral mucosal non-malignant lesions in the western Sicilian population. 38
27374359 2016
67
Diseases of the tongue. 38
27343960 2016
68
[Dermatological diseases of the external male genitalia : Part 2: Infectious and malignant dermatological]. 38
27364818 2016
69
Zoon balanitis: A comprehensive review. 38
27890945 2016
70
Enhanced contact endoscopy for the assessment of the neoangiogenetic changes in precancerous and cancerous lesions of the oral cavity and oropharynx. 38
26138390 2016
71
A new approach for treatment of precancerous lesions with curcumin solid-lipid nanoparticle-loaded gels: in vitro and clinical evaluation. 38
26146889 2016
72
Various forms of tobacco usage and its associated oral mucosal lesions. 38
27034758 2016
73
A case of erythroplasia of Queyrat successfully treated with combination carbon dioxide laser vaporization and surgery. 38
25475424 2016
74
Dermatoses of the Glans Penis in Korea: A 10-Year Single Center Experience. 38
26848217 2016
75
Non-Invasive Techniques for Detection and Diagnosis of Oral Potentially Malignant Disorders. 38
26888696 2016
76
Oral Cancer: An Evaluation of Knowledge and Awareness in Undergraduate Dental Students and the General Public. 38
27351736 2016
77
Potentially malignant oral lesions: clinicopathological correlations. 38
27074232 2016
78
Expression of NF-κB and IL-6 in oral precancerous and cancerous lesions: An immunohistochemical study. 38
26595830 2016
79
Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation. 38
25804887 2015
80
Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review. 38
26163301 2015
81
Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions. 38
26173924 2015
82
Two cases of erythroplasia of Queyrat with persistent post-treatment inflammation after histological remission of epithelial dysplasia. 38
26105658 2015
83
Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology. 38
25975717 2015
84
A novel target for oral cancer chemoprevention? Notch quite, yet…. 38
25712052 2015
85
Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review. 38
25315968 2015
86
Comparison of the prevalence of human papilloma virus infection in histopathologically confirmed premalignant oral lesions and healthy oral mucosa by brush smear detection. 38
25600980 2015
87
Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. 38
24482244 2015
88
Outcome of excision of oral erythroplakia. 38
25467247 2015
89
The use of CA-IX as a diagnostic method for oral leukoplakia. 38
25297562 2015
90
Prevalence and Risk Factors for Oral Potentially Malignant Disorders in Indian Population. 38
26347822 2015
91
Evaluation of AgNORs in Oral Potentially Malignant Lesions. 38
26417370 2015
92
Precancerous lesions of oral mucosa. 38
25516862 2014
93
Role of cytokine gene (interferon-γ, transforming growth factor-β1, tumor necrosis factor-α, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese. 38
25458044 2014
94
Oral potentially malignant disorders in a large dental population. 38
25591015 2014
95
Repair of oral mucosal defects with cryopreserved human amniotic membrane grafts: prospective clinical study. 38
25132569 2014
96
Assessing oral cancer knowledge and awareness among Malaysian dental and medical students. 38
25579526 2014
97
Tobacco use, Body Mass Index, and Potentially Malignant Disorders Among petrol fillers in Pimpri-Pune (India): A descriptive study. 38
25422802 2014
98
Aerodigestive cancers: oral cancer. 38
25198382 2014
99
Clinicopathologic evaluation of lesions associated with tobacco usage. 38
25576115 2014
100
Contact Endoscopy of mucosal lesions of oral cavity - Preliminary experience. 38
25378780 2014
101
To Study the Prevalence of Premalignancies in Teenagers having Betel, Gutkha, Khaini, Tobacco Chewing, Beedi and Ganja Smoking Habit and Their Association with Social Class and Education Status. 38
25356006 2014
102
Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma. 38
24415717 2014
103
Queyrat erythroplasia accompanied by bladder cancer in a circumcised male. 38
24927357 2014
104
Penile preservation surgery in a case of erythroplasia of Queyrat involving the glans penis and distal urethra. 38
23675865 2014
105
Intraoral basal cell carcinoma, a rare neoplasm: report of three new cases with literature review. 38
24202723 2014
106
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará. 38
24964281 2014
107
Prevalence of potentially malignant oral mucosal lesions among tobacco users in Jeddah, Saudi Arabia. 38
24568491 2014
108
Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report. 38
24135797 2014
109
Oral potentially malignant disorders among dental patients: a pilot study in Jordan. 38
25556487 2014
110
[Oral medicine 11. Red and blue lesions of the oral mucosa]. 38
24340687 2013
111
Smokeless tobacco use, tooth loss and oral health issues among adults in Cameroon. 38
24250322 2013
112
Pseudoepitheliomatous keratotic and micaceous balanitis. 38
24339464 2013
113
Anogenital malignancies and premalignancies: facts and controversies. 38
23806153 2013
114
[Precancerous tumors and carcinomas in situ of the skin]. 38
23657620 2013
115
Prevalence of oral mucosal lesions in dental patients with tobacco smoking, chewing, and mixed habits: A cross-sectional study in South India. 38
23983566 2013
116
Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy. 38
23318121 2013
117
Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer. 38
22725270 2013
118
A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. 38
22949076 2013
119
Salivary markers of oxidative stress in patients with oral premalignant lesions. 38
23092610 2012
120
Leukoplakia and erythroplakia of the oral mucosa--a brief overview. 38
23957095 2012
121
Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment. 38
22524200 2012
122
Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients. 38
21888568 2012
123
Erythroplasia of Queyrat refractory to photodynamic therapy. 38
22831651 2012
124
Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development. 38
22525603 2012
125
Erythroplasia of queyrat. 38
24765462 2012
126
Human papilloma virus and oral lesions in gutka eating subjects in Karachi. 38
22414350 2012
127
[Chemoprevention of oral cancer--clinical and experimental studies]. 38
22590920 2012
128
[Update on current care guidelines: oral cancer]. 38
22612027 2012
129
Oral cancer and dentists: knowledge, attitudes and practices in a South Colombian context. 38
23230635 2012
130
[Smokeless tobacco]. 38
22099403 2011
131
Diagnostic procedures in dermatology. 38
21855731 2011
132
Use of narrow band imaging guidance in the management of oral erythroplakia. 38
21036438 2011
133
Oral cancer and oral erythroplakia: an update and implication for clinicians. 38
21884139 2011
134
Anogenital malignancies and pre-malignancies. 38
21272092 2011
135
Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. 38
21615500 2011
136
Multimodality approach to optical early detection and  mapping of oral neoplasia. 38
21806268 2011
137
MAGE-A antigens in lesions of the oral mucosa. 38
20174843 2011
138
Prevalence of oral mucosal abnormalities in addiction treatment centre residents in Southern Ireland. 38
21441065 2011
139
Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. 38
21396880 2011
140
The practical use of cytology for diagnosis in dermatology. 38
20553359 2011
141
Histopathological aspects of benign epithelial tumors located in areas of friction or chronic irritation of the tongue. 38
21892526 2011
142
Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat. 38
21849768 2011
143
Is workplace screening for potentially malignant oral disorders feasible in India? 38
20738753 2010
144
[Potentially malignant disorders of the oral mucosa: terminology and classification]. 38
20739038 2010
145
[Upper aerodigestive tract erythroplakia]. 38
20739037 2010
146
Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions. 38
19953611 2010
147
Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. 38
20308005 2010
148
Absence of PCR-detectable human papilloma virus in erythroplasia of Queyrat using a comparative control group. 38
20444743 2010
149
Treating skin cancer with topical cream. 38
20408746 2010
150
[A scientometric analysis of leukoplakia and erythroplakia]. 38
20387174 2010
151
[Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery]. 38
19943030 2010
152
A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision. 38
20523838 2009
153
The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions. 38
19640683 2009
154
[Leukoplakia and erythroplakia--two orale precursor lesions]. 38
19813163 2009
155
Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression. 38
19679297 2009
156
Cytogenetic monitoring in human oral cancers and other oral pathology: the micronucleus test in exfoliated buccal cells. 38
19778244 2009
157
Prevalence of oral lesions in the dental office. 38
19903642 2009
158
Biomarkers in dysplasia of the oral cavity: a systematic review. 38
19442563 2009
159
Penile cancer: epidemiology, pathogenesis and prevention. 38
18607597 2009
160
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. 38
18674954 2009
161
Oral erythroplakia and speckled leukoplakia: retrospective analysis of 13 cases. 38
19575119 2009
162
Dysplasia of the upper aerodigestive tract squamous epithelium. 38
20596993 2009
163
Treatment of cutaneous tumors with topical 5% imiquimod cream. 38
19841702 2009
164
Erythroplasia of Queyrat with Zoon's balanitis: a diagnostic dilemma. 38
19050221 2008
165
Oral pathology: erythroplakia. 38
19326610 2008
166
The significance of Epstein Barr virus (EBV) & DNA topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). 38
19021895 2008
167
Vulvar intraepithelial neoplasia (erythroplasia of Queyrat). 38
18786281 2008
168
Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience. 38
19356643 2008
169
Erythroplasia of Queyrat of the glans penis on a background of Zoon's plasma cell balanitis. 38
18412812 2008
170
[Oral erythroplakia and erythroleukoplakia: red and red-white dysplastic lesions of the oral mucosa--part 1: epidemiology, etiology, histopathology and differential diagnosis]. 38
18578206 2008
171
[Oral erythroplakia and erythroleukoplakia: red and red-white dysplastic lesions of the oral mucosa--part 2: cytodiagnosis, pathogenesis, therapy, and prognostic aspects]. 38
18619138 2008
172
A rare case of penile cancer in situ metastasizing to lymph nodes. 38
18542829 2007
173
Oral cancer awareness of undergraduate medical and dental students. 38
18005417 2007
174
A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. 38
17823667 2007
175
Oral premalignant lesions: is a biopsy reliable? 38
17448135 2007
176
Self-awareness of premalignant oral lesions among veterans attending six U.S. Veterans Affairs Medical Centers. 38
17658182 2007
177
Molecular genetics of premalignant oral lesions. 38
17305612 2007
178
Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity. 38
17326123 2007
179
[High risk lesions of the oral mucosa--Diagnosis, therapy and follow-up in two cases]. 38
17708425 2007
180
Erythroplasia of Queyrat treated with imiquimod 5% cream. 38
17052503 2006
181
Total glans resurfacing for premalignant lesions of the penis: initial outcome data. 38
16925748 2006
182
Surgical treatment of erythroleukoplakia in lower lip with carbon dioxide laser radiation. 38
16721625 2006
183
[Treatment of oral mucosal diseases: Part I. Diagnosis and treatment of oral leukoplakia, erythroplakia and melanoplakia]. 38
17074193 2006
184
Oral lesions of 500 habitual psychoactive substance users in Chennai, India. 38
16412976 2006
185
Long-term treatment outcome of oral premalignant lesions. 38
16316774 2006
186
Oral cancer and pre-cancer in Myanmar: a short review. 38
16519764 2006
187
Association between diabetes mellitus and pre-malignant oral diseases: a cross sectional study in Kerala, India. 38
16049982 2006
188
Effective management of smoking in an oral dysplasia clinic in London. 38
16390464 2006
189
Very early cytological and DNA-cytometric diagnosis of in situ carcinoma in an immunosuppressed liver transplant recipient. 38
16393256 2006
190
Erythroplasia of Queyrat with urethral involvement: treatment with carbon dioxide laser vaporization. 38
16416620 2005
191
The role of the dental team in preventing and diagnosing cancer: 5. Alcohol and the role of the dentist in alcohol cessation. 38
16262033 2005
192
Carbon dioxide laser treatment of erythroplasia of Queyrat: a revisited treatment to this condition. 38
16164731 2005
193
Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. 38
16008656 2005
194
Oral erythroplakia--a review. 38
15975518 2005
195
Bowen's disease involving the urethra. 38
15863869 2005
196
Chlamydia trachomatis infection in sexually active adolescents and young women. 38
16082066 2005
197
Betel quid without tobacco as a risk factor for oral precancers. 38
15172639 2004
198
Knowledge and behaviors of primary care physicians on oral cancer in Italy. 38
15006620 2004
199
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. 38
12838415 2004
200
Plasma cell cheilitis. 38
14678543 2004
201
Recurrent verruciform xanthoma of the vulva. 38
14668556 2004
202
Photodynamic therapy--mechanism and employment. 38
16146137 2004
203
[Detecting HPV DNA in tissues of external genital squamous cell carcinoma in situ by PCR-RFLP technique]. 38
14714308 2003
204
Risk factors for multiple oral premalignant lesions. 38
12949809 2003
205
Treatment of Bowen's disease and erythroplasia of Queyrat. 38
14616349 2003
206
Socioeconomic status, lifestyle factors and oral premalignant lesions. 38
12907205 2003
207
Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. 38
12452865 2002
208
Oral and oral pharyngeal cancer: an update on incidence and epidemiology, identification, advances in treatment, and outcomes. 38
12789999 2002
209
Common skin disorders of the penis. 38
12175386 2002
210
Topical cidofovir for erythroplasia of Queyrat of the glans penis. 38
12174131 2002
211
Oral and pharyngeal cancer: knowledge and opinions of dentists in British Columbia and Nova Scotia. 38
12119092 2002
212
[Update review on prevention and early diagnosis in oral cancer]. 38
12242764 2002
213
Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. 38
12120703 2002
214
Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN). 38
11854058 2002
215
Radiotherapy of skin tumors. 38
12079218 2002
216
Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases. 38
11805779 2002
217
Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat. 38
12145439 2002
218
Laser therapy for carcinoma in situ of the penis. 38
11586199 2001
219
Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. 38
11722712 2001
220
Premalignant oral mucosal diseases. 38
11577670 2001
221
[A research on the correlation of oral mucosal patches stria diseases and epithelial dysplasia]. 38
14994028 2001
222
Maryland dental hygienists' knowledge and opinions of oral cancer risk factors and diagnostic procedures. 38
11495194 2001
223
Oral mucosal lesions in adult Chinese. 38
11437225 2001
224
[Precancerous lesions of the buccal mucosa]. 38
11446145 2001
225
Oral cancer. The importance of early diagnosis and treatment. 38
11705251 2001
226
[Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions]. 38
11220242 2001
227
Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. 38
11120491 2001
228
A comprehensive review of oral cancer. 38
12004680 2001
229
Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions. 38
11016684 2000
230
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. 38
10951274 2000
231
Chewing tobacco, alcohol, and the risk of erythroplakia. 38
10919731 2000
232
[Precancer stages of the oral mucosa: a review]. 38
11005096 2000
233
Bowen's disease of the glans penis (erythroplasia of Queyrat) in plasma cell balanitis. 38
10879310 2000
234
Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. 38
10792247 2000
235
Abnormalities of the FHIT gene in human oral carcinogenesis. 38
10732756 2000
236
Penile cancer among patients with genital lichen sclerosus. 38
10570372 1999
237
Experimental intervention study about recognition of erythroplakia by undergraduate dental students. 38
10858764 1999
238
Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. 38
10233277 1999
239
[Contemporary model for treatment of erythroplakia]. 38
10375916 1999
240
A high prevalence of p53 mutations in pre-malignant oral erythroplakia. 38
9935172 1999
241
Loss of basement membrane components laminin and type IV collagen parallels the progression of oral epithelial neoplasia. 38
9777393 1998
242
Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. 38
9688297 1998
243
A clinicopathological study of the pre-malignant conditions of oral cavity. 38
23119427 1998
244
Cancer precursors. 38
9669604 1998
245
Cryosurgery in oral lesions. 38
9585902 1998
246
Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. 38
9682768 1998
247
The detection of human papillomavirus 16 DNA in erythroplasia of Queyrat invading the urethra. 38
9536246 1998
248
A national epidemiological survey of oral mucosal lesions in Malaysia. 38
9355776 1997
249
[Detecting HPV DNA in tissue of epidermal neoplasms]. 38
10453555 1997
250
[Chemoprevention in cancer of the head and neck]. 38
9131918 1997
251
[Mouth neoplasms: a review]. 38
11921919 1996
252
Urology image quiz. Erythroplasia of Queyrat. 38
8732219 1996
253
Frequent gene deletions in potentially malignant oral lesions. 38
8611386 1996
254
Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. 38
8842478 1996
255
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. 38
8667255 1996
256
Detection of chromosome instability of tissue fields at risk: in situ hybridization. 38
9027599 1996
257
Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. 38
7583906 1995
258
Cancer of the tongue. 38
7585269 1995
259
Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. 38
7584579 1995
260
Erythroplakia: the dangerous red mucosa. 38
9002888 1995
261
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. 38
7646764 1995
262
Intraoral squamous cell carcinoma in human immunodeficiency virus infection. A clinicopathologic study. 38
7552863 1995
263
Early diagnosis and prevention of oral cancer and precancer: report of Symposium III. 38
7546134 1995
264
Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis. 38
7549809 1995
265
The diagnosis and treatment of precancerous lesions. 38
9552676 1995
266
Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. 38
7621010 1995
267
An overview of the oral manifestations of AIDS-related Kaposi's sarcoma. 38
7758045 1995
268
[The recognition and treatment of mouth mucosal diseases (II). Hyperkeratosis, leukoplakia, erythroplakia, lichenoid changes and erosions of the mouth mucosa]. 38
7494979 1995
269
Bionutrition and oral cancer in humans. 38
7632867 1995
270
Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. 38
8584455 1995
271
Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. 38
7529754 1994
272
The p53 status of cultured human premalignant oral keratinocytes. 38
7917902 1994
273
Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. 38
8080726 1994
274
Oral leukoplakia and erythroplakia: a review and update. 38
7833463 1994
275
[Precancerous conditions of the oral cavity. Note II--Pathology and clinical course. Critical review of the literature]. 38
7984130 1994
276
Carcinoma in situ of the penis. 38
8126803 1994
277
[Groups at high risk for skin cancer]. 38
7785248 1994
278
Oral cancer education and HIV-associated malignancies. 38
7811603 1994
279
Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. 38
8289004 1993
280
[Roentgen therapy of malignant skin tumors]. 38
8171406 1993
281
p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. 38
8245568 1993
282
Erythroplasia of Queyrat treated with isotretinoin. 38
8105246 1993
283
Early genetic changes during upper aerodigestive tract tumorigenesis. 38
8412199 1993
284
A long-term evaluation of the CIN-lesions. A clinicopathological study. 38
8200375 1993
285
[Autoimmune hemolytic anemia with medullary erythroplasia and black serum with methemalbuminemia]. 38
8426949 1993
286
[Oral lichen planus and cancer. Apropos of 2 cases]. 38
8456245 1993
287
Conservative extirpative treatment of cancer of the penis. 38
1574819 1992
288
Premalignant and early carcinomas of the penis and scrotum. 38
1574813 1992
289
Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. 38
1736473 1992
290
[Cancer of the penis and its treatment]. 38
1373451 1992
291
Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia. 38
1791144 1991
292
Pre-malignant lesions of the oral mucosa in a South African sample--a clinicopathological study. 38
1962315 1991
293
[Course and morphology studies in penile cancer]. 38
2046196 1991
294
Carcinoma in situ of penis. Is distinction between erythroplasia of Queyrat and Bowen's disease relevant? 38
2247911 1990
295
[Plasmocellular balanoposthitis of Zoon]. 38
2383046 1990
296
CO2 laser treatment of erythroplasia of Queyrat. 38
2341665 1990
297
Spindle-cell carcinoma: a case report. 38
2337562 1990
298
[Chlamydia trachomatis infection in women]. 38
2287310 1990
299
Common oral conditions in the elderly. 38
2683689 1989
300
Oral lichenoid dysplasia: a clinicopathologic analysis. 38
2755689 1989
301
Carbon dioxide laser treatment of erythroplasia of Queyrat. 38
2501369 1989
302
Appearance, site of occurrence, and physical and clinical characteristics of oral carcinoma in Torino, Italy. 38
2720601 1989
303
Clinical manifestations of oral precancer and cancer. 38
2623669 1989
304
Early detection, diagnosis, and management of oral and oropharyngeal cancer. 38
2495159 1989
305
Clinical manifestations of oral precancer and cancer. 38
2916168 1989
306
[Precancerous oral lesions. Diagnostic and therapeutic protocol]. 38
2763844 1989
307
Extramammary Paget's disease of the oral mucosa with in situ carcinoma of minor salivary gland ducts. 38
2847572 1988
308
Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. 38
3177749 1988
309
Bowenoid papulosis of the penis: successful management with neodymium:YAG laser. 38
3373609 1988
310
Surgical treatment of premalignant lesions of the oral mucosa. 38
3125262 1987
311
[Bowen's disease of the anus]. 38
3426143 1987
312
[A case of erythroplakia of the palate, tongue and gingiva]. 38
3685719 1987
313
Plasma cell balinitis of Zoon. 38
3801829 1986
314
Plasma cell orificial mucositis. Report of a case and review of the literature. 38
3777979 1986
315
Erythroplasia--clinical features and differential diagnosis. 38
3469051 1986
316
Dysplasia in salivary gland ducts in sublingual leukoplakia and erythroplakia. 38
3460008 1986
317
Carcinoma in situ of the glans penis and distal urethra. 38
3700824 1986
318
Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. 38
3002589 1986
319
Queyrat's erythroplasia of the prepuce: a case-report. 38
4082852 1985
320
A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith-Pindborg method of standardization. 38
3926973 1985
321
Carbon dioxide laser treatment of external genital lesions. 38
3925610 1985
322
[Dystrophy and precancerous changes in the vulva: symptoms, histology and therapy]. 38
2989078 1985
323
Soft-X-ray therapy in Bowen's disease and erythroplasia of Queyrat. 38
4043475 1985
324
Erythroplasia of Queyrat. 38
6720494 1984
325
Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. 38
6537892 1984
326
Papulosquamous lesions of glans penis. 38
6229081 1984
327
Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. 38
6610492 1984
328
[Erythroplasia of Queyrat--statistical studies of 61 cases in Japan]. 38
6663796 1983
329
[Erythroplakia of the oral mucosa]. 38
6575889 1983
330
[Erythroplakia of the oral mucosa]. 38
6590541 1983
331
Erosive lichen planus involving the glans penis alone. 38
6832878 1983
332
Leukoplakia and erythroplakia of the mouth. 38
6964200 1982
333
Correlative clinico-pathological evaluation of oral premalignancy. 38
6809916 1982
334
Epidemiologic study of 600 villagers of oral precancerous lesions in Bilugyun: preliminary report. 38
6213357 1982
335
Treatment of erythroplasia of Queyrat with liquid nitrogen cryosurgery. 38
7073983 1982
336
[Diagnosis of vulvar diseases. 2. Discussion and conclusions for practice]. 38
7076077 1982
337
Erythroplasia of Queyrat in a partially circumcised man. 38
7068968 1982
338
[CO2 laser coagulation of benign changes of the portio vaginalis in comparison with the endocoagulation technic (Semm's method)]. 38
6819742 1982
339
Erythroplakia and the detection of oral malignancy. 38
6951213 1981
340
Erythroplasia (Queyrat) of conjunctiva. 38
7217386 1981
341
Erythroplakia of Queyrat of the oral mucosa. A report of 2 cases. 38
7250473 1981
342
Bowenoid papulosis of the penis. 38
7463570 1981
343
Combination of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia. 38
7349810 1981
344
Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. 38
6259230 1980
345
[Chronic plasmocellular balanitis and erythroplasia]. 38
7442854 1980
346
Carbon dioxide rapid superpulsed laser treatment of erythroplasia of Queyrat. 38
6773202 1980
347
Erythroplasia of Queyrat involving the distal urethra. 38
6103893 1980
348
Oral lichen planus, leukoplakia and erythroplakia: some observations on diagnosis and clinical management. 38
6934472 1980
349
[Bowen's disease and erythroplasia of Queyrat]. 38
7376965 1980
350
Topical fluorouracil therapy for precancers and cancers of the skin. 38
159921 1979
351
[Erythroplakia of the mouth mucosa]. 38
283893 1978
352
Leukoplakia and erythroplakia in early oral cancer...an update. 38
290694 1978
353
[Carcinoma of the penis: review of our cases]. 38
697423 1978
354
Erythroplasia: the earliest sign of asymptomatic oral cancer. 38
273632 1978
355
Oral lichen planus, leukoplakia and erythroplakia: some observations on diagnosis and clinical management. 38
289871 1978
356
Surgical treatment of erythroplasia of Queyrat. 38
622420 1978
357
Malignant penile horn. 38
926252 1977
358
[The intraepithelial carcinoma of the mouth mucosa and its anatomo-clinical variants]. 38
271360 1977
359
Erythroplasia vs. leukoplasia in the diagnosis of early asymptomatic oral squamous carcinoma. 38
865567 1977
360
Surgical treatment of erythroplasia of Queyrat. 38
322170 1977
361
[X-ray irradiation of dermatoses in the genital area]. 38
194873 1977
362
Review of erythroplasia of Queyrat and its treatment. 38
788296 1976
363
Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. 38
991073 1976
364
Metastasizing erythroplasia Queyrat. Report of a case. 38
78630 1976
365
[Histopathologic study of the squamous cell carcinoma of the oral mucosa. 2. Erythroplasia (author's transl)]. 38
1063235 1975
366
Erythroplakia of the oral cavity. 38
1182656 1975
367
Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. 38
1173631 1975
368
Loss of epithelial blood group antigens A and B in oral premalignant lesions. 38
1155097 1975
369
[Treatment of Bowen's disease, Bowen's carcinoma and Gueyrat's erythroplasia with special reference to low-voltage radiotherapy]. 38
4448634 1974
370
Erythroplasia of Queyrat. 38
4851903 1974
371
Erythroplasia of Queyrat. 38
4830884 1974
372
Letter: Erythroplasia of Queyrat. 38
4819128 1974
373
Erythroplasia of Queyrat. A clinicopathologic and histochemical study. 38
4757930 1973
374
[Penile spinocellular carcinoma developing in a case of Queyrat's erythroplasia]. 38
4731824 1973
375
Erythroplakia of the mouth and carcinoma-in-situ of the oral mucosa. 38
4516324 1973
376
Erythroplasia of Queyrat (Bowen's disease of the glans penis). 38
4745883 1973
377
Erythroplakia of the mouth. 38
4509562 1972
378
[Bowen's disease of the vulva--case of erythroplasia, later developing to squamous cell carcinoma]. 38
4542242 1972
379
[Case of Queyrat's erythroplasia]. 38
4655338 1972
380
[One case of erythroplasia of Queyrat of jugal mucosa (or the erythematous form of Bowen's disease)]. 38
4512525 1972
381
Benign and malignant erythroplasia: report of two cases. 38
4503654 1972
382
[Erythroplasia of the glans penis which changed to carcinoma: report of a case]. 38
5106902 1971
383
[Frequency and evaluation of erythroplakia of the portio]. 38
5550237 1971
384
[Prevention of cervix neoplasm by electrocoagulation of erythroplakia]. 38
4105371 1971
385
Erythroplasia of Queyrat: repor. of a patient successfully treated with topical 5-fluorouracil. 38
5539006 1971
386
Queyrat's erythroplasia of the penis treated by beta particle irradiation. 38
5377686 1969
387
Erythroplasia of Queyrat treated with topical 5-fluorouracil. 38
5347767 1969
388
[Leukoplasia and erythroplasia]. 38
5264403 1969
389
[Bowen's disease (pure hyperplasia, simple hyperplasia, Queyrat's erythroplasia]. 38
5360172 1969
390
[Colchamine treatment for erythroplasia of Queyrat of the penis]. 38
5406684 1969
391
[Results of plastic surgery in Queyrat's erythroplasia]. 38
4915930 1968
392
[Erythroplasia of the genitals]. 38
5747698 1968
393
[Treatment of erythroplakia of the vaginal portion of the uterus with electrocagulation]. 38
5671737 1968
394
[Queirat's erythroplasia]. 38
5619904 1967
395
[Erythroplasia of Queyrat as a consequence of arsenobenzene therapy]. 38
6046435 1967
396
Erythroplasia of Queyrat--carcinoma in situ. 38
5588774 1967
397
Erythroplasia of Queyrat. 38
5332906 1966
398
[On a case of Queyrat's erythroplasia of the penis]. 38
5852088 1965
399
[CONSIDERATIONS ON 2 CASES OF CHRONIC CIRCUMSCRIBED PLASMA CELL BALANOPOSTHITIS OF ZOON (BENIGN PLASMOCYTE ERYTHROPLASIA)]. 38
14348063 1965
400
[VULVAR ERYTHROPLASIA TREATED WITH BAYER E39]. 38
14251238 1964
401
ERYTHROPLASIA OF QUEYRAT OF THE BUCCAL MUCOUS MEMBRANE. 38
14130231 1964
402
NON-INFECTIOUS INFLAMMATORY AND NEOPLASTIC DISORDERS OF THE MALE GENITALIA. 38
14131400 1964
403
CYTOLOGIC PATTERNS IN ERYTHROPLASIA OF THE VULVA. 38
14063655 1963
404
[Queyrat's erythroplasia of the penis cured by radiotherapy]. 38
14004169 1963
405
[CYTOLOGICAL STUDIES ON VULVAR ERYTHROPLASIA (WITH A DISCUSSION ON THE PATHOLOGICAL ENTITY)]. 38
14133038 1963
406
Carcinoma developing in Queyrat's erythroplasia. 38
13911300 1962
407
[On erythroplakia of the portio vaginalis and cervical carcinoma and their early detection, with special reference to colpomicroscopy and submicroscopic findings in the cells]. 38
13872492 1962
408
Malignant erythroplasia of Queyrat. (Bowen's disease of the mucous membrane). 38
14007028 1961
409
Erythroplasia of the female genitalia. Report of two cases of a benign from (plasmacytosis pudendi). 38
13717160 1961
410
Considerations on Bowen's disease and its fundamental histopathological particularities. Its relationship with Queyrat's erythroplasia. 38
14479529 1961
411
Erythroplasia of Queyrat; report of a case with recurrence after cessation of topical hydrocortisone. 38
13636451 1959
412
Erythroplasia of Queyrat. 38
13633492 1959
413
[Leukoplakia and erythroplakia of the cervix uteri]. 38
13833777 1959
414
A case of fatal metastasizing erythroplasia. 38
13560708 1958
415
Erythroplasia of Queyrat. 38
13486231 1957
416
[Benign plasmocytic erythroplasia]. 38
13472341 1957
417
Erythroplasia of Queyrat. 38
13436773 1957
418
Benign plasma-cell erythroplasia. 38
13413058 1957
419
Erythroplasia of Queyrat. 38
13554402 1957
420
[Etiology of erythroplasia of the penis]. 38
13422798 1957
421
[Case of erythroplasia of the glans with special reference to the etiology of erythroplasia]. 38
13506934 1957
422
Erythroplasia of Queyrat; an unusual instance in a Negro patient involving the penis and progressing to invasive carcinoma. 38
13346173 1956
423
[Ulcerous erythroplasia of the penis; cure with radiotherapy with corticotherapy; effectiveness of this combined therapy in dermatology]. 38
13396474 1956
424
[Benign circumscribed erythroplasia-like vulvo-vaginitis; associated vaginal moniliasis; favorable effect of mycostatin]. 38
13396494 1956
425
Erythroplasia associated with multiple intra-epidermal carcinomata. 38
13329297 1956
426
[Queyrat's erythroplasia]. 38
14380066 1955
427
Erythroplasia of Queyrat with invasive carcinoma and with coincidental carcinoma in situ of urethra. 38
14368705 1955
428
[Vulvar erythroplasia]. 38
14363913 1955
429
[Case of erythroplasia degenerating into spinocellular carcinoma]. 38
13223838 1954
430
[Clinical and histological study of two cases of erythroplasia]. 38
13113003 1953
431
Queyrat's erythroplasia with carcinomatous invasion: report of an unusual case. 38
13062393 1953
432
Erythroplasia of Queyrat. 38
13062392 1953
433
[Report of a case of Queyrat's erythroplasia]. 38
13060716 1953
434
Erythroplasia; report of a case with cure. 38
12975863 1952
435
[Differential diagnosis between chronic circumscribed benign plasmacellular balanitis and Queyrat's erythroplasia]. 38
13013418 1952
436
[Cytodiagnosis in erythroplasia]. 38
14869969 1951
437
[Colchicine therapy of erythroplasia]. 38
14879550 1951
438
[Vulvar erythroplasia of 20 years duration, cured in two months by estrogens]. 38
14801600 1950
439
A case of erythroplasia Queyrat. 38
15432042 1950
440
The erythroplasia of Queyrat; two case reports. 38
15408879 1950
441
A case for diagnosis; erythroplasia? 38
18135869 1949
442
Malignant dyskeratosis, erythroplasia of Queyrat type; report of a case. 38
18135849 1949
443
Pemphigus erythematosus and erythroplasia of the penis. 38
18124917 1949
444
Erythroplasia of Queyrat; report of a case. 38
18895267 1948
445
Erythroplasia of Queyrat; report of ten cases. 38
18110545 1948
446
A case for diagnosis (intraepidermal epithelioma? erythroplasia of Queyrat?). 38
20343997 1947
447
A case for diagnosis (dermatitis venenata? erythroplasia?). 38
20343472 1947
448
A case for diagnosis (psoriasis; lichen planus; erythroplasia of Queyrat?). 38
21001294 1946
449
Erythroplasia. 38
19992505 1942

Variations for Erythroplakia

Expression for Erythroplakia

Search GEO for disease gene expression data for Erythroplakia.

Pathways for Erythroplakia

Pathways related to Erythroplakia according to GeneCards Suite gene sharing:

(showing 2, show less)
# Super pathways Score Top Affiliating Genes
1 11.45 ALDH1A1 ABCG2
2 10.52 BMI1 ABCG2

GO Terms for Erythroplakia

Sources for Erythroplakia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....